Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 study.

Sohai DK, Keller MD, Hanley PJ, Hoq F, Kukadiya D, Datar A, Reynolds E, Copertino DC, Lazarski C, McCann CD, Tanna J, Shibli A, Lang H, Zhang A, Chansky PA, Motta C, Huynh TT, Dwyer B, Wilson A, Lynch R, Mota TM, Conce Alberto WD, Brumme ZL, Kinloch NN, Cruz CRY, MacLaren Ehui L, Henn S, Brad Jones R, Bollard CM

Open source

DOI: 10.1038/s41467-025-59810-2
Published: 2025 May 15
Container: Nature communications
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41467-025-59810-2,
  title = {Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 study.},
  author = {Sohai DK and Keller MD and Hanley PJ and Hoq F and Kukadiya D and Datar A and Reynolds E and Copertino DC and Lazarski C and McCann CD and Tanna J and Shibli A and Lang H and Zhang A and Chansky PA and Motta C and Huynh TT and Dwyer B and Wilson A and Lynch R and Mota TM and Conce Alberto WD and Brumme ZL and Kinloch NN and Cruz CRY and MacLaren Ehui L and Henn S and Brad Jones R and Bollard CM},
  year = {2025},
  journal = {Nature communications},
  doi = {10.1038/s41467-025-59810-2},
  url = {https://doi.org/10.1038/s41467-025-59810-2}
}

RIS

TY  - JOUR
TI  - Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 study.
AU  - Sohai DK
AU  - Keller MD
AU  - Hanley PJ
AU  - Hoq F
AU  - Kukadiya D
AU  - Datar A
AU  - Reynolds E
AU  - Copertino DC
AU  - Lazarski C
AU  - McCann CD
AU  - Tanna J
AU  - Shibli A
AU  - Lang H
AU  - Zhang A
AU  - Chansky PA
AU  - Motta C
AU  - Huynh TT
AU  - Dwyer B
AU  - Wilson A
AU  - Lynch R
AU  - Mota TM
AU  - Conce Alberto WD
AU  - Brumme ZL
AU  - Kinloch NN
AU  - Cruz CRY
AU  - MacLaren Ehui L
AU  - Henn S
AU  - Brad Jones R
AU  - Bollard CM
PY  - 2025
JO  - Nature communications
DO  - 10.1038/s41467-025-59810-2
UR  - https://doi.org/10.1038/s41467-025-59810-2
ER  -

APA

DK, S., MD, K., PJ, H., F, H., D, K., A, D., E, R., DC, C., C, L., CD, M., J, T., A, S., H, L., A, Z., PA, C., C, M., TT, H., B, D., A, W., R, L., TM, M., WD, C. A., ZL, B., NN, K., CRY, C., L, M. E., S, H., R, B. J., & CM, B. (2025). Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 study.. Nature communications. https://doi.org/10.1038/s41467-025-59810-2

Source records

pubmed · retrieved 2026-09-25T20:31:36.195Z